Damon Reed

Trials

Studies that name Damon Reed as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:46 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07477457 · A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

  Memorial Sloan Kettering Cancer Center · recruiting · Osteosarcoma, Metastasis · principal investigator
• Ph1
  NCT01683149 · Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies

  H. Lee Moffitt Cancer Center and Research Institute · completed · Solid Tumor · principal investigator
• Ph1
  NCT01528046 · Metformin in Children With Relapsed or Refractory Solid Tumors

  H. Lee Moffitt Cancer Center and Research Institute · completed · Solid Tumors, Primary Brain Tumors · principal investigator
• Ph1
  NCT01324180 · Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)

  H. Lee Moffitt Cancer Center and Research Institute · completed · Acute Lymphoblastic Leukemia · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.